Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 241983, 10 pages
http://dx.doi.org/10.1155/2015/241983
Research Article

Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells

Department of Hepatobiliary Surgery, Affiliated Yijishan Hospital of Wannan Medical College, Wuhu 241001, China

Received 11 August 2015; Revised 31 October 2015; Accepted 3 November 2015

Academic Editor: Shinichi Aishima

Copyright © 2015 Xiao-Peng Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Shirabe, S. Wakiyama, T. Gion et al., “Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma—results of 152 resected cases,” Hepato-Gastroenterology, vol. 54, no. 79, pp. 2084–2087, 2007. View at Google Scholar · View at Scopus
  3. O. Nakashima and M. Kojiro, “Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 8, no. 5, pp. 404–409, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Y. Chan, S. C. Chan, K. S. H. Chok et al., “Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?” Liver Transplantation, vol. 19, no. 4, pp. 411–419, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Noble and J. Pasi, “Epidemiology and pathophysiology of cancer-associated thrombosis,” British Journal of Cancer, vol. 102, no. 1, pp. S2–S9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Falanga, M. Panova-Noeva, and L. Russo, “Procoagulant mechanisms in tumour cells,” Best Practice and Research: Clinical Haematology, vol. 22, no. 1, pp. 49–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Tsuruo and N. Fujita, “Platelet aggregation in the formation of tumor metastasis,” Proceedings of the Japan Academy Series B: Physical and Biological Sciences, vol. 84, no. 6, pp. 189–198, 2008. View at Publisher · View at Google Scholar
  8. I. Vlodavsky, Y. Friedmann, M. Elkin et al., “Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis,” Nature Medicine, vol. 5, no. 7, pp. 793–802, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. P. H. Kussie, J. D. Hulmes, D. L. Ludwig et al., “Cloning and functional expression of a human heparanase gene,” Biochemical and Biophysical Research Communications, vol. 261, no. 1, pp. 183–187, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Toyoshima and M. Nakajima, “Human heparanase. Purification, characterization, cloning and expression,” Journal of Biological Chemistry, vol. 274, no. 34, pp. 24153–24160, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Chen, Y.-W. Dang, D.-Z. Luo, Z.-B. Feng, and X.-L. Tang, “Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study,” Oncology Research, vol. 17, no. 4, pp. 183–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Chen, X.-P. Chen, M.-S. Wu, W. Cui, and M. Zhong, “Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma,” European Journal of Medical Research, vol. 19, no. 1, pp. 45–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S.-J. Yu, X.-H. Kang, J.-N. Zhang et al., “Effects of small interfering RNA targeting heparanase-1 combined with heparin on invasiveness of mouse hepatocellular carcinoma cell lines,” Chinese Journal of Cancer, vol. 29, no. 9, pp. 816–823, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Xiong, M.-H. Lü, Y.-H. Fan et al., “Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo,” International Journal of Oncology, vol. 40, no. 5, pp. 1601–1609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. L.-D. Zheng, G.-S. Jiang, J.-R. Pu et al., “Stable knockdown of heparanase expression in gastric cancer cells in vitro,” World Journal of Gastroenterology, vol. 15, no. 43, pp. 5442–5448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Pisano, I. Vlodavsky, N. Ilan, and F. Zunino, “The potential of heparanase as a therapeutic target in cancer,” Biochemical Pharmacology, vol. 89, no. 1, pp. 12–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. A. McKenzie, “Heparanase: a target for drug discovery in cancer and inflammation,” British Journal of Pharmacology, vol. 151, no. 1, pp. 1–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Nadir and B. Brenner, “Heparanase procoagulant effects and inhibition by heparins,” Thrombosis Research, vol. 125, supplement 2, pp. S72–S76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Nadir, B. Brenner, L. Fux, I. Shafat, J. Attias, and I. Vlodavsky, “Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII,” Haematologica, vol. 95, no. 11, pp. 1927–1934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Nadir and B. Brenner, “Heparanase multiple effects in cancer,” Thrombosis Research, vol. 133, supplement 2, pp. S90–S94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Goldshmidt, E. Zcharia, M. Cohen et al., “Heparanase mediates cell adhesion independent of its enzymatic activity,” The FASEB Journal, vol. 17, no. 9, pp. 1015–1025, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Peng, Z. Zhang, J. Wu et al., “A critical role for ZDHHC2 in metastasis and recurrence in human hepatocellular carcinoma,” BioMed Research International, vol. 2014, Article ID 832712, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Liu, H. Fang, H. Chen et al., “An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation,” PLoS ONE, vol. 7, no. 6, Article ID e38659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Lever, M. J. Rose, E. A. McKenzie, and C. P. Page, “Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium,” American Journal of Physiology—Cell Physiology, vol. 306, no. 12, pp. C1184–C1190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Gomes, E. O. Kozlowski, L. Borsig, F. C. Teixeira, I. Vlodavsky, and M. S. Pavao, “Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: effect on P-selectin, heparanase, metastasis and cellular recruitment,” Glycobiology, vol. 25, no. 4, pp. 386–393, 2015. View at Publisher · View at Google Scholar
  26. L. Zhang, J.-N. Wang, J.-M. Tang et al., “VEGF is essential for the growth and migration of human hepatocellular carcinoma cells,” Molecular Biology Reports, vol. 39, no. 5, pp. 5085–5093, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Zbytek, J. A. Carlson, J. Granese, J. Ross, M. Mihm Jr., and A. Slominski, “Current concepts of metastasis in melanoma,” Expert Review of Dermatology, vol. 3, no. 5, pp. 569–585, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Levy-Adam, N. Ilan, and I. Vlodavsky, “Tumorigenic and adhesive properties of heparanase,” Seminars in Cancer Biology, vol. 20, no. 3, pp. 153–160, 2010. View at Publisher · View at Google Scholar